Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2017

Open Access 01-12-2017 | Research

Effects of caffeine on the detection of ischemia in patients undergoing adenosine stress cardiovascular magnetic resonance imaging

Authors: Simon Greulich, Philipp Kaesemann, Andreas Seitz, Stefan Birkmeier, Eed Abu-Zaid, Francesco Vecchio, Udo Sechtem, Heiko Mahrholdt

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2017

Login to get access

Abstract

Background

Adenosine stress cardiovascular magnetic resonance (CMR) can detect significant coronary artery stenoses with high diagnostic accuracy. Caffeine is a nonselective competitive inhibitor of adenosine2A-receptors, which might hamper the vasodilator effect of adenosine stress, potentially yielding false-negative results. Much controversy exists about the influence of caffeine on adenosine myocardial perfusion imaging. Our study sought to investigate the effects of caffeine on ischemia detection in patients with suspected or known coronary artery disease (CAD) undergoing adenosine stress CMR.

Methods

Thirty patients with evidence of myocardial ischemia on caffeine-naïve adenosine stress CMR were prospectively enrolled and underwent repeat adenosine stress CMR after intake of 200 mg caffeine. Both CMR exams were then compared for evaluation of ischemic burden.

Results

Despite intake of caffeine, no conversion of a positive to a negative stress study occurred on a per patient basis. Although we found significant lower ischemic burden in CMR exams with caffeine compared to caffeine-naïve CMR exams, absolute differences varied only slightly (1 segment based on a 16-segment model, 3 segments on a 60-segment model, and 1 ml in total ischemic myocardial volume, p < 0.001 each). Moreover, no relevant ischemia (≥2 segments in a 16-segment model) was missed by prior ingestion of caffeine.

Conclusions

Although differences were small and no relevant myocardial ischemia had been missed, prior consumption of caffeine led to significant reduction of ischemic burden, and might lower the high diagnostic and prognostic value of adenosine stress CMR. Therefore, we suggest that patients should still refrain from caffeine prior adenosine stress CMR tests.
Literature
1.
go back to reference Hage FG, Iskandrian AE. The effect of caffeine on adenosine myocardial perfusion imaging: time to reassess? J Nucl Cardiol. 2012;19(3):415–9.CrossRefPubMed Hage FG, Iskandrian AE. The effect of caffeine on adenosine myocardial perfusion imaging: time to reassess? J Nucl Cardiol. 2012;19(3):415–9.CrossRefPubMed
2.
go back to reference Fishman WH, Sonnenblick EH. Cardiovascular Pharmacotherapeutics. 8th ed. New York: McGraw-Hill; 1997. p. 125–31. Fishman WH, Sonnenblick EH. Cardiovascular Pharmacotherapeutics. 8th ed. New York: McGraw-Hill; 1997. p. 125–31.
3.
go back to reference Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.CrossRefPubMed Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.CrossRefPubMed
4.
go back to reference Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.CrossRefPubMed Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.CrossRefPubMed
5.
go back to reference Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson. 2010;12:29.CrossRefPubMedPubMedCentral Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson. 2010;12:29.CrossRefPubMedPubMedCentral
6.
go back to reference Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. JACC Cardiovasc Imaging. 2017; Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. JACC Cardiovasc Imaging. 2017;
7.
go back to reference Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187–226.CrossRefPubMed Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187–226.CrossRefPubMed
8.
go back to reference Lapeyre AC 3rd, Goraya TY, Johnston DL, Gibbons RJ. The impact of caffeine on vasodilator stress perfusion studies. J Nucl Cardiol. 2004;11(4):506–11.CrossRefPubMed Lapeyre AC 3rd, Goraya TY, Johnston DL, Gibbons RJ. The impact of caffeine on vasodilator stress perfusion studies. J Nucl Cardiol. 2004;11(4):506–11.CrossRefPubMed
9.
go back to reference Namdar M, Koepfli P, Grathwohl R, Siegrist PT, Klainguti M, Schepis T, et al. Caffeine decreases exercise-induced myocardial flow reserve. J Am Coll Cardiol. 2006;47(2):405–10.CrossRefPubMed Namdar M, Koepfli P, Grathwohl R, Siegrist PT, Klainguti M, Schepis T, et al. Caffeine decreases exercise-induced myocardial flow reserve. J Am Coll Cardiol. 2006;47(2):405–10.CrossRefPubMed
10.
go back to reference Thames MD, Kinugawa T, Dibner-Dunlap ME. Reflex sympathoexcitation by cardiac sympathetic afferents during myocardial ischemia. Role of adenosine. Circulation. 1993;87(5):1698–704.CrossRefPubMed Thames MD, Kinugawa T, Dibner-Dunlap ME. Reflex sympathoexcitation by cardiac sympathetic afferents during myocardial ischemia. Role of adenosine. Circulation. 1993;87(5):1698–704.CrossRefPubMed
11.
go back to reference Smits P, Aengevaeren WR, Corstens FH, Thien T. Caffeine reduces dipyridamole-induced myocardial ischemia. J Nucl Med. 1989;30(10):1723–6.PubMed Smits P, Aengevaeren WR, Corstens FH, Thien T. Caffeine reduces dipyridamole-induced myocardial ischemia. J Nucl Med. 1989;30(10):1723–6.PubMed
12.
go back to reference Smits P, Corstens FH, Aengevaeren WR, Wackers FJ, Thien T. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med. 1991;32(8):1538–41.PubMed Smits P, Corstens FH, Aengevaeren WR, Wackers FJ, Thien T. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med. 1991;32(8):1538–41.PubMed
13.
go back to reference Lee JC, Fraser JF, Barnett AG, Johnson LP, Wilson MG, McHenry CM, et al. Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis. J Nucl Cardiol. 2012;19(3):474–81.CrossRefPubMed Lee JC, Fraser JF, Barnett AG, Johnson LP, Wilson MG, McHenry CM, et al. Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis. J Nucl Cardiol. 2012;19(3):474–81.CrossRefPubMed
14.
go back to reference Zoghbi GJ, Htay T, Aqel R, Blackmon L, Heo J, Iskandrian AE. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol. 2006;47(11):2296–302.CrossRefPubMed Zoghbi GJ, Htay T, Aqel R, Blackmon L, Heo J, Iskandrian AE. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol. 2006;47(11):2296–302.CrossRefPubMed
15.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging Committee of the Council on clinical cardiology of the American Heart Association. Circulation. 2002;105(4):539–42.CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging Committee of the Council on clinical cardiology of the American Heart Association. Circulation. 2002;105(4):539–42.CrossRefPubMed
16.
go back to reference Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298(4):181–6.CrossRefPubMed Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298(4):181–6.CrossRefPubMed
17.
go back to reference Fredholm BB. Astra award lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995;76(2):93–101.CrossRefPubMed Fredholm BB. Astra award lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995;76(2):93–101.CrossRefPubMed
18.
go back to reference Liguori A, Hughes JR, Grass JA. Absorption and subjective effects of caffeine from coffee, cola and capsules. Pharmacol Biochem Behav. 1997;58(3):721–6.CrossRefPubMed Liguori A, Hughes JR, Grass JA. Absorption and subjective effects of caffeine from coffee, cola and capsules. Pharmacol Biochem Behav. 1997;58(3):721–6.CrossRefPubMed
19.
go back to reference Smits P, Boekema P, De Abreu R, Thien T. Van 't Laar a. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol. 1987;10(2):136–43.CrossRefPubMed Smits P, Boekema P, De Abreu R, Thien T. Van 't Laar a. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol. 1987;10(2):136–43.CrossRefPubMed
20.
go back to reference Greulich S, Steubing H, Birkmeier S, Grün S, Bentz K, Sechtem U, et al. Impact of arrhythmia on diagnostic performance of adenosine stress CMR in patients with suspected or known coronary artery disease. J Cardiovasc Magn Reson. 2015;17:94.CrossRefPubMedPubMedCentral Greulich S, Steubing H, Birkmeier S, Grün S, Bentz K, Sechtem U, et al. Impact of arrhythmia on diagnostic performance of adenosine stress CMR in patients with suspected or known coronary artery disease. J Cardiovasc Magn Reson. 2015;17:94.CrossRefPubMedPubMedCentral
21.
go back to reference Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update; Society for Cardiovascular Magnetic Resonance Board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2013;15:91.CrossRefPubMedPubMedCentral Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update; Society for Cardiovascular Magnetic Resonance Board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2013;15:91.CrossRefPubMedPubMedCentral
22.
go back to reference Klem I, Heitner JF, Shah DJ, Cawley P, Behar V, Weinsaft J, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630–8.CrossRefPubMed Klem I, Heitner JF, Shah DJ, Cawley P, Behar V, Weinsaft J, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630–8.CrossRefPubMed
23.
go back to reference Greulich S, Bruder O, Parker M, Schumm J, Grün S, Schneider S, et al. Comparison of exercise electrocardiography and stress perfusion CMR for the detection of coronary artery disease in women. J Cardiovasc Magn Reson : off J Soc cardiovascular magnetic. Resonance. 2012;14:36. Greulich S, Bruder O, Parker M, Schumm J, Grün S, Schneider S, et al. Comparison of exercise electrocardiography and stress perfusion CMR for the detection of coronary artery disease in women. J Cardiovasc Magn Reson : off J Soc cardiovascular magnetic. Resonance. 2012;14:36.
24.
go back to reference Di Bella EV, Parker DL, Sinusas AJ. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med: Off J Soc Magnetic Resonance Med Soc Magnetic Resonance Med. 2005;54:1295–9.CrossRef Di Bella EV, Parker DL, Sinusas AJ. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med: Off J Soc Magnetic Resonance Med Soc Magnetic Resonance Med. 2005;54:1295–9.CrossRef
25.
go back to reference Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461–74.CrossRefPubMed Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461–74.CrossRefPubMed
26.
go back to reference Shaw LJ, Berman DS, Picard MH, Friedrich MG, Kwong RY, Stone GW, et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging. 2014;7(6):593–604.CrossRefPubMedPubMedCentral Shaw LJ, Berman DS, Picard MH, Friedrich MG, Kwong RY, Stone GW, et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging. 2014;7(6):593–604.CrossRefPubMedPubMedCentral
27.
go back to reference Majd-Ardekani J, Clowes P, Menash-Bonsu V, Nunan TO. Time for abstention from caffeine before an adenosine myocardial perfusion scan. Nucl Med Commun. 2000;21(4):361–4.CrossRefPubMed Majd-Ardekani J, Clowes P, Menash-Bonsu V, Nunan TO. Time for abstention from caffeine before an adenosine myocardial perfusion scan. Nucl Med Commun. 2000;21(4):361–4.CrossRefPubMed
28.
go back to reference Zheng XM, Williams RC. Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging. J Nucl Med Technol. 2002;30(3):123–7.PubMed Zheng XM, Williams RC. Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging. J Nucl Med Technol. 2002;30(3):123–7.PubMed
29.
go back to reference Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart. 2009;95(1):49–55.CrossRefPubMed Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart. 2009;95(1):49–55.CrossRefPubMed
30.
go back to reference Kelle S, Chiribiri A, Vierecke J, Egnell C, Hamdan A, Jahnke C, et al. Long-term prognostic value of dobutamine stress CMR. J Am Coll Cardiol Img. 2011;4:161–72.CrossRef Kelle S, Chiribiri A, Vierecke J, Egnell C, Hamdan A, Jahnke C, et al. Long-term prognostic value of dobutamine stress CMR. J Am Coll Cardiol Img. 2011;4:161–72.CrossRef
31.
go back to reference Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;50:1174–9.CrossRefPubMed Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;50:1174–9.CrossRefPubMed
32.
go back to reference Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M, et al. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. JACC Cardiovasc Imaging. 2017; Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M, et al. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. JACC Cardiovasc Imaging. 2017;
33.
go back to reference Reyes E, Loong CY, Harbinson M, Donovan J, Anagnostopoulos C, Underwood SR. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll Cardiol. 2008;52(24):2008–16.CrossRefPubMed Reyes E, Loong CY, Harbinson M, Donovan J, Anagnostopoulos C, Underwood SR. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll Cardiol. 2008;52(24):2008–16.CrossRefPubMed
Metadata
Title
Effects of caffeine on the detection of ischemia in patients undergoing adenosine stress cardiovascular magnetic resonance imaging
Authors
Simon Greulich
Philipp Kaesemann
Andreas Seitz
Stefan Birkmeier
Eed Abu-Zaid
Francesco Vecchio
Udo Sechtem
Heiko Mahrholdt
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2017
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/s12968-017-0412-0

Other articles of this Issue 1/2017

Journal of Cardiovascular Magnetic Resonance 1/2017 Go to the issue